Endocrine-disrupting pesticides and selected hormonally dependent cancers

Scandinavian Journal of Work, Environment and Health

Volumn 31, Issue SUPPL. 1, 2005, Pages 55-61

  Muir, Kenneth R ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

1,1 dichloro 2,2 tris(p chlorophenyl); Breast cancer; Dichlorodiphenyl trichloroethane; Hormone mimics; Prostate cancer; Xenoestrogens

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHYLENE; BRCA1 PROTEIN; BRCA2 PROTEIN; CHLORPHENOTANE; ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR; PESTICIDE;

CANCER; ENDOCRINE SYSTEM; PESTICIDE;

BREAST CANCER; CANCER CELL; CANCER RISK; CELL PROLIFERATION; ENVIRONMENTAL EXPOSURE; EPIDEMIOLOGICAL DATA; GENETIC SUSCEPTIBILITY; HUMAN; NOTE; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR;

BREAST NEOPLASMS; ENDOCRINE DISRUPTORS; FEMALE; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; PESTICIDES; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 24944528389     PISSN: 03553140     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (63)

1. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Antonculver H. Medical hypothesis - xenoestrogens as preventable causes of breast-cancer. Environ Health Perspect 1993;101:372-7.
2. Davis DL, Telang NT, Osborne MP, Bradlow HL. Medical hypothesis: bifunctional genetic-hormonal pathways to breast cancer. Environ Health Perspect 1997;105:571-6.
3. Soto AM, Justicia H, Wray JW, Sonnenschein C. P-nonylphenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect 1991;92;167-73.
4. Olea N, Pulgar R, Perez P, Olea-Serrano F, Rivas A, Novillo-Fertrel A, et al. Estro-genicity of resin-based composites and sealants used in dentistry. Environ Health Perspect 1996; 104:298-305.
5. Giam CS, Neff GS, Atlas EL, Chan HS. Phthalate ester plasticizers: a new class of marine pollutants. Science 1978; 199:419-21.
6. Coleman MP, et al. Trends in cancer incidence and mortality. Leon: International Agency for Research on Cancer (IARC); 1993. IARC scientific publications no 121.
7. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation and breast cancer risk. Epidemiol Rev 1993;15:17-35.
8. Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001;344: 276-85.
9. Mendes JJA. The endocrine disrupters: a major medical challenge. Food Chem Toxicol 2002;40:781-8.
10. Wolff MS, Toniolo PG. Environmental organochlorine exposure as a potential etiologic factor in breast cancer. Environ Health Perspect 1995;103 suppl 7:141-5.
11. Snedeker SM. Pesticides and breast cancer risk: a review of DDT, DDE and dieldrin. Environ Health Perspect 2001; 109:35-47.
12. Adami HO, Lipworth L, Titus-Ernstoff L, et al. Organochlorine compounds and estrogen-related cancers in women. Cancer Causes Control 1995;6:551-66.
13. Hunter DJ, Hankinson SE, Laden F, et al. Plasma organochlorine levels and the risk of breast cancer. N Engl J Med 1997; 337:1253-8.
14. Ahlborg UG, et al. Organochlorine compounds in relation to breast cancer, endometrial cancer and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol 1995;25:463-531.
15. Gammon MD, Wolff MS, Neugut AI, Eng SM, Teitelbaum SL, Britton JA, et al. Environmental toxins and breast cancer on long island. II. organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev 2002;11 August:686-97.
16. Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N. Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 1993;85:648-52.
17. Moysich KB, Ambrosone CB, Vena JE, et al. Environmental organochlorine exposure and postmenopausal breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:181-8.
18. Falck F Jr, Ricci A Jr, Wolff MS, Godbold J, Deckers P. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 1992;47:143-6.
19. Wolff MS, Zeleniuch-Jacquotte A, Dubin N, Toniolo P. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev 2000;9:271-7.
20. Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N. Breast cancer and serum organochlorines: a prospective study among white, black and Asian women. J Natl Cancer Inst 1994;86:589-99.
21. Millikan R, DeVoto E, Duell EJ, et al. Dichlorodiphenyldichloroethene, polychlorinated biphenyls and breast cancer among African-American and white women in North Carolina. Cancer Epidemiol Biomarkers Prev 2000;9:1233-240.
22. Somogyi A, Beck H. Nurturing and breast-feeding: exposure to chemicals in breast milk. Environ Health Perspect 1993;101:45-52.
23. Rogan WJ, Gladen BC, McKinney JD, et al. Polychlorinated biphenyls (PCBs) and dichlorodiphenyl dichloroethene (DDE) in human milk: effects of maternal factors and previous lactation. Am J Public Health 1986;76:172-7.
24. Olaya-Contreras P, Rodriguez-Villamil J, Posso-Valencia HJ, Cortez JE. Organochlorine exposure and breast cancer risk in Colombian women. Cad Saude Publica 1998;14 suppl 3:125-32.
25. Romieu I, Hernandez-Avila M, Lazcano-Ponce E, Weber JP, Dewailly E. Breast cancer, lactation history and serum organochlorines. Am J Epidemiol 2000;152:363-70.
26. Wasserman M, Nogueira DP, Tomatis L, Mirra AP, Shibata H, Arie G, et al. Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ Contam Toxicol 1976;15:478-84.
27. Zheng TZ, Holford TR, Mayne ST, Tessari J, Ward B, Carter D, et al. Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2′-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomarkers Prev 2000;9:167-74.
28. Stellman SD, Djordjevic MV, Britton JA, Muscat JE, Citron ML, Kemeny M, et al. Breast cancer risk in relation to adipose concentrations of organochlorine pesticides and polychlorinated biphenyls in Long Island, New York. Cancer Epidemiol Biomarkers Prev 2000;9:1241-9.
29. Aronson SF, Klotz DM, Collins BM, Vonier PM, Guillette LJ Jr, McLachlan JA. Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science 1996;27u2:1489-92. Retracted by McLachlan JA. In: Science 1997;277(5325):462-3.
30. Van't Veer P, Lobbezoo IE, MartinMoreno JM, Guallar E, GomezAracena J, Kardinaal AFM, et al. DDT (dicophane) and postmenopausal breast cancer in Europe: case-control study. BMJ 1997;315:81-5.
31. Zheng TZ, Holford TR, Mayne ST, Ward B, Carter D, Owens PH, et al. DDE and DDT in breast adipose tissue and risk of female breast cancer. Am J Epidemiol 1999;150:453-8.
32. Lopez-Carrillo L, Blair A, Lopez-Cervantes M, Cebrian M, Rueda C, Reyes R, et al. Dichlorodiphenyltrichloroethane serum levels and breast cancer risk: a case-control study from Mexico. Cancer Res 1997;57:3728-32.
33. Schecter A, Toniolo P, Dai LC, Thuy LTB and Wolff MS. Blood levels of DDT and breast cancer risk among women living in the North of Vietnam. Arch Environ Contam Toxicol 1997;33:453-6.
34. Mendonca GAS, Eluf-Neto J, Andrada-Serpa MJ, Carmo PAO, Barreto HHC, Inomata ONK. Organochlorines and breast cancer: a case-control study in Brazil. Int J Cancer 1999;83:596-600.
35. Hoyer AP, Jorgensen T, Grandjean P, Hartvig HB. Repeated measurements of organochlorine exposure and breast cancer risk (Denmark). Cancer Causes Control 2000;11:177-84.
36. Dorgan JF, Brock JW, Rothman N, Needham LL, Miller R, Stephenson HE, et al. Serum organochlorine pesticides and PCBs and breast cancer risk: results from a prospective analysis (USA). Cancer Causes Control 1999;10:1-11.
37. Helzlsouer KJ, Alberg AJ, Huang HY, Hoffman SC, Strickland PT, Brock JW, et al. Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev 1999;8:525-32.
38. Hoyer AP, Grandjean P, Jorgensen T, Brock JW, Hartvig HB. Organochlorine exposure and risk of breast cancer. Lancet 1998;352:1816-20.
39. Laden F, Hankinson SE, Wolff MS, Colditz GA, Willett WC, Speizer FE, et al. Plasma organochlorine levels and the risk of breast cancer: an extended follow-up in the nurses' health study. Int J Cancer 2001;91:568-74.
40. Laden F, Collman G, Iwamoto K, Alberg AJ, Berkowitz GS, Freudenheim JL, et al. 1,1-dichloro-2,2-bis(p-chlorophenyl)-ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five US studies. J Natl Cancer Inst 2001;93:768-76.
41. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Hatshman K, Tavtigian S, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266:66-71.
42. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, et al. Localisation of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265:2088-91.
43. Malkin D, Li FP, Strong LC, et al. Germline p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 1990;250:1233-8.
44. Buchert ET, Woosley RL, Swain SM, Oliver SJ, Coughlin SS, Pickle L, et al. Relationship of CYP2D6 (debrisoquine hydroxylase) genotype to breast cancer susceptibility. Pharmacogenetics 1993;3:322-7.
45. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, et al. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms and breast cancer risk. JAMA 1996;276(18):1494-501.
46. Ambrosone CB, Freudenheim JL, Graham S, Marshall JR, Vena JE, Brasure JR, et al. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk. Cancer Res 1995;55:3483-5.
47. Shields PG, Ambrosone CB, Graham S, Bowman ED, Harrington AM, Gillenwater KA, et al. A cytochrome P4502E1 genetic polymorphism and tobacco smoking in breast cancer. Mol Carcinogen 1996;17,144-50.
48. Vineis P, Malats N, Lang M, d'Errico A, Caporaso N, Cuzick J, et al. Metabolic polymorphisms and susceptibility to cancer. Lyon: World Health Organisation, International Agency for Research on Cancer (IARC);.IARC scientific publications no 148.
49. Damstra T, Barlow S, Bergman A, Kavlock R, Van Der Kraak G. IPCS global assessment of the state-of-the-science of endocrine disruptors. Geneva: World Health Organization; 2002.
50. Muir KR, Rattanamongkolgul S, Armstrong S, Sriamporn S, Vatanasapt V. Pesticide practice and risk of breast cancer: a case-control study in Thailand.
51. Zober A, Hoffmann G, Ott M, Will W, Germann C, Ravenzwaay Bv. Study of morbidity of personnel with potential exposure to vinclozolin. Occup Environ Med, 1994;52:233-241.
52. Asp S, Riihimaki V, Hernberg S, Pukkala E. Mortality and cancer morbidity of Finnish chlorophenoxy herbicide applicators: an 18 year prospective follow-up. Am J Ind Med 1994;26:243-53.
53. Saracci R, Kogevinas M, Bertazzi P-A, et al. Cancer mortality in workers exposed to chlorophenoxy herbicides and chlorphenols. Lancet 1991;338(8774):1027-32.
54. Fingerhut M, Halperin W, Marlow D, et al. Cancer mortality in workers exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. N Engl J Med 1991;324:212-8.
55. Cantor K, Booze C. Mortality among aerial pesticide applicators and flight instructors: a reprint. Arch Environ Health 1991;46(2):110-16.
56. Wiklund K, Dich J, Holm L-E, Eklund G. Risk of cancer in pesticide applicators in Swedish agriculture. Br J Ind Med 1989;46:809-14.
57. Bond G, Wetterstroem N, Roush G, McLaren E, Lipps T, Cook R. Cause specific mortality among employees engaged in manufacture, formulation or packaging of 2,4-dichlorophenoxyacetic acid and related salts. Br J Ind Med 1988;45:98-105.
58. Coggon D, Pannett B, Winter PD, Acheson ED, Bonsall J. Mortality of workers exposed to 2 methyl-4 chlorophenoxyacetic acid. Scand J Work Environ Health 1986;12:448-54.
59. Lynge E. A follow-up study of cancer incidence among workers in manufacture of phenoxy herbicides in Denmark. Br J Cancer 1985;52:259-70.
60. Blair A, Grauman D, Lubin J, Fraumeni J. Lung cancer and other causes of death among licensed pesticide applicators. J Natl Cancer Inst 1983;71(1):31-7.
61. Riihimäki V, Asp S, Hemberg S. Mortality of 2,4-dichlorophenoxyacetic acid and 2,4,5-trichlorophenoxyacetic acid herbicide applicators in Finland: first report of an ongoing prospective cohort study. Scand J Work Environ Health 1982;8:37-42.
62. Wang H, MacMahon B. Mortality of pesticide applicators. J Occup Med 1979;21(11):741-3.
63. Kay K. Occupational cancer risks for pesticide workers. Environ Res 1974;7:243-71.